期刊文献+

碱性成纤维细胞生长因子及其受体在胃癌及癌前病变中的表达及其意义

Expression and significance of basic fibroblast growth factor and fibroblast growth factor receptor-2 in gastric cancer
下载PDF
导出
摘要 目的探讨碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)及成纤维细胞生长因子受体-2(fibroblast growth factor receptor-2,FGFR-2)在胃癌组织中的表达及其意义。方法应用免疫组化SP法检测100例胃癌及癌旁组织,bFGF和FGFR-2的表达及两者之间的关系。结果胃癌中bFGF和FGFR-2表达明显高于癌旁组织及正常组织(P<0.01),胃癌组织中bFGF、FGFR-2表达的水平与临床病理分期有关,中晚期胃癌bFGF及FGFR-2阳性率明显高于早期胃癌(P<0.05),胃癌组织中bFGF与FGFR-2表达呈正相关,随bFGF表达的增高FGFR-2表达亦增高(P<0.05)。结论 bFGF和FGFR-2在胃癌组织中表达明显增高可能与肿瘤的发生发展有关。 Objective To investigate the expression, location and respective Significance of basic fibroblast growth factor (bFGF) and fibroblast growth factor receptor - 2 ( FGFR - 2 ) in human gastric careinomal. Methods The expressions of bFGF and FGFR -2 in 100 gastric cancer tissues samples and normal tissues adjacent to the tumor samples and the relationship between the expression of bFGF and FGFR - 2 were detected by using immunohistoehemical method. Results The bFGF and FGFR - 2 were up - regulated in cancer compared with normal tissues. The expression level of bFGF and FGFR -2 in gastric cancer tissues were significantly higher than in adjacent tissues and normal tissues (P 〈0.01 ). The expression level and clinical pathological staging of the mid - late gastric bFGF and FGFR - 2 positive was significantly higher than early gastric cancer ( P 〈 0. 05 ). The positive relationship was found between bFGFand FGFR - 2 expression in gastric carcinoma( P 〈 0.05 ). Conclusion The over - expressions of bFGF and FGFR - 2 appear in the gastric carcinoma tissues and might be involved in the invasiveness and metastasis of gastric carcinoma.
作者 王菲 张庆
出处 《中国医学创新》 CAS 2010年第35期1-3,共3页 Medical Innovation of China
关键词 胃癌 碱性成纤维细胞生长因子 成纤维细胞生长因子受体-2 Gastric cancer Basic fibroblast growth factor Fibroblast growth factor receptor -2
  • 相关文献

参考文献2

二级参考文献22

  • 1张予辉,王辰,庞宝森,翟振国,翁心植.血管内皮细胞生长因子反义寡核苷酸联合低分子肝素治疗小鼠Lewis肺癌的研究[J].中华医学杂志,2006,86(11):749-752. 被引量:1
  • 2Roberto C, Femando P, Paolo T, et al .The heparins and cancer:review of clinical trials and biological properties. Vascular Med,2004,9:205-213.
  • 3Yu MK, Lee DY, Kim YS, et al. Antiangiogenic and Apoptotic Properties of a Novel Amphiphilic Folate-Heparin-Lithocholate Derivative Having Cellular Internality for Cancer Therapy. Pharma Res ,2007,24:705-714.
  • 4Abe R, Fujita Y, Yamagishi S, et al. Angiogenesis and metastasis inhibitors for the treatment of malignant melanoma. Mini Rev Med Chem, 2007, 7:649-661.
  • 5Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc Res Tech, 2003, 60:70-75
  • 6Pisano C, Aulicino C, Vesci L, et al. low-molecular-weight glycolsplit heparin as an antiangiogenic VEGF antagonist. Glycobiology, 2005, 15 : 1C- 6C.
  • 7Casu B, Guerrini M, Guglieri S, et al. Undersulfated and glycol-split heparins endowed with antiangiogenic activity. Med Chem,2004,47:838-848.
  • 8Norrby K. 2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis.Int J Exp Pathol,2000, 81 : 191-198.
  • 9Bjornsson TD, Schneider DE, Hecht AR, et al. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo dispositon. J Pharmacol Exp Ther, 1998, 245:804-808.
  • 10Thourani VH, Brar SS, Kennedy TP, et al. Nonanticoagulant heparin inhibits NF-kB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol,2000,278 : H2084-2093.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部